NCT00950508
Completed
Not Applicable
European Multicenter Plasma Exchange Trial (Empet): A Controlled, Open, Randomised, Multicenter Study In Patients With Acute Liver Failure
ConditionsAcute Liver Failure
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Liver Failure
- Sponsor
- Rigshospitalet, Denmark
- Enrollment
- 183
- Locations
- 3
- Primary Endpoint
- mortality
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The aim of this study is to examine if high-volume plasma exchange has a positive effect on mortality in patients with acute liver failure.
Investigators
Dr. Fin Stolze Larsen
Senior consultant
Rigshospitalet, Denmark
Eligibility Criteria
Inclusion Criteria
- •Patients with acute liver failure in encephalopathy grade 2-4
Exclusion Criteria
- •alcoholic hepatitis
- •primary non function liver graft or graft dysfunction
- •known chronic liver disease
- •known malignancies
- •clinical suspicion of brain death
Outcomes
Primary Outcomes
mortality
Time Frame: at day 3, day 7
Study Sites (3)
Loading locations...
Similar Trials
Terminated
Phase 2
Plasma Exchange for Renal VasculitisWegener's GranulomatosisMicroscopic PolyangiitisNCT01408836Cambridge University Hospitals NHS Foundation Trust150
Completed
Not Applicable
Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19COVID 19NCT04457349Alexandria University10
Completed
Not Applicable
Trial of Plasma Exchange for Acute Renal Failure at the Onset of MyelomaMultiple MyelomaAcute Renal FailureNCT00120263London Health Sciences Centre92
Terminated
Phase 3
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%Acute-On-Chronic Liver FailureNCT03702920Grifols Therapeutics LLC275
Completed
Phase 2
Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT02479802Instituto Grifols, S.A.13